metformin has been researched along with HIV in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin use was associated with improved CD4 recovery (p=0." | 1.40 | Cohort study of diabetes in HIV-infected adult patients: evaluating the effect of diabetes mellitus on immune reconstitution. ( Cary, MS; Chikuse, F; Kwadiba, G; Moyo, D; Mushisha, O; Reid, MJ; Steenhoff, AP; Tanthuma, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zaongo, SD | 1 |
| Chen, Y | 1 |
| Moyo, D | 1 |
| Tanthuma, G | 1 |
| Cary, MS | 1 |
| Mushisha, O | 1 |
| Kwadiba, G | 1 |
| Chikuse, F | 1 |
| Steenhoff, AP | 1 |
| Reid, MJ | 1 |
| Coll, B | 1 |
| van Wijk, JP | 1 |
| Parra, S | 1 |
| Castro Cabezas, M | 1 |
| Hoepelman, IM | 1 |
| Alonso-Villaverde, C | 1 |
| de Koning, EJ | 1 |
| Camps, J | 1 |
| Ferre, N | 1 |
| Rabelink, TJ | 1 |
| Tous, M | 1 |
| Joven, J | 1 |
1 review available for metformin and HIV
| Article | Year |
|---|---|
Metformin may be a viable adjunctive therapeutic option to potentially enhance immune reconstitution in HIV-positive immunological non-responders.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dysbiosis; | 2023 |
1 trial available for metformin and HIV
| Article | Year |
|---|---|
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Chemokine CCL2; Cholesterol, | 2006 |
1 other study available for metformin and HIV
| Article | Year |
|---|---|
Cohort study of diabetes in HIV-infected adult patients: evaluating the effect of diabetes mellitus on immune reconstitution.
Topics: Adult; Antiretroviral Therapy, Highly Active; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positi | 2014 |